Executive Summary Canada Pharmaceuticals And Healthcare Industry SWOT Canada Political SWOT Canada Economic SWOT Pharmaceutical Business Environment Ratings Table: Pharmaceutical Business Environment Rankings Limits To Potential Returns Risks To Realisation Of Returns Canada - Market Summary Regulatory Regime Intellectual Property Developments Pricing And Reimbursement Issues Ontario Breaks The Mould Industry Developments Product Approvals And Launches Pharmaceutical Re-import Policy Company Activity National Pharmaceuticals Strategy Generics Sector Table: Foreign-To-Canadian Price Ratios, 2005 Research And Development Sector Pharmacy Sector Industry Forecast Scenario Overall Market Forecast Table: Canada: Drug Market Indicators Key Growth Factors - Industry Table: Canadian Health Expenditure Indicators Key Growth Factors - Macroeconomic Table: Canada- Economic Activity OTC Market Forecast Table: Canadian OTC Drugs Market Forecast Indicators (US$mn unless otherwise stated) Generics Market Forecast Table: Canadian Generics Market Indicators Patented Market Forecast Table: Canadian Patented Market Indicators Export/Import Forecasts Table: Sectoral Trade Indicators (US$mn) Other Healthcare Data Forecasts Table: Canadian Socio-demographic Indicators Competitive Landscape Table: Canada’s Leading Generics Firms, 2006 Company Profiles Leading Multinational Manufacturers Pfizer Merck & Co GlaxoSmithKline Sanofi-Aventis Novartis Indigenous Manufacturers Apotex Our Forecast Modelling
How We Generate Our Industry Forecasts Pharmaceutical Industry Pharmaceutical Business Environment Ratings Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Weighting Table: Weighting Of Components Sources
